Which proton pump inhibitor is listed as inappropriate for older adults due to risks such as C. diff infection, pneumonia, bone loss, and fractures?

Study for the AGS Beers Criteria Test. Prepare with flashcards and multiple choice questions, each with hints and explanations. Get ready for your exam with comprehensive resources!

Multiple Choice

Which proton pump inhibitor is listed as inappropriate for older adults due to risks such as C. diff infection, pneumonia, bone loss, and fractures?

Explanation:
Long-term suppression of stomach acid with a proton pump inhibitor in older adults is viewed as potentially inappropriate because it raises risks of C. difficile infection, pneumonia, and bone-related issues like osteoporosis and fractures. Dexlansoprazole, as a proton pump inhibitor, carries these same risks when used chronically or without a clear, ongoing indication. The Beers Criteria emphasizes using the lowest effective dose for the shortest duration and re-evaluating need regularly, especially in the elderly, where the harm/benefit balance is less favorable. If acid suppression is still needed, consider the shortest- duration therapy, dose reduction, or stepping down to an alternative (such as an H2 blocker) and deprescribing when possible.

Long-term suppression of stomach acid with a proton pump inhibitor in older adults is viewed as potentially inappropriate because it raises risks of C. difficile infection, pneumonia, and bone-related issues like osteoporosis and fractures. Dexlansoprazole, as a proton pump inhibitor, carries these same risks when used chronically or without a clear, ongoing indication. The Beers Criteria emphasizes using the lowest effective dose for the shortest duration and re-evaluating need regularly, especially in the elderly, where the harm/benefit balance is less favorable. If acid suppression is still needed, consider the shortest- duration therapy, dose reduction, or stepping down to an alternative (such as an H2 blocker) and deprescribing when possible.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy